Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12907714 | 0.95 | CNR2 (0.91) | CNR2CNR1 | |
| SCHEMBL30961589 | 0.93 | CNR2 (0.88) | CNR2CNR1 | |
| SCHEMBL1009687 | 0.93 | CNR2 (0.87) | CNR2CNR1 | |
| SCHEMBL4903857 | 0.90 | CNR2 (0.82) | CNR2CNR1 | |
| SCHEMBL2734336 | 0.89 | CNR2 (0.83) | CNR2CNR1 | |
| Hydrochloric Acid SCHEMBL4916328 | 0.89 | CNR2 (0.80) | CNR2CNR1 | |
| SCHEMBL16475874 | 0.89 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL4911796 | 0.88 | CNR2 (0.81) | CNR2CNR1 | |
| SCHEMBL4462537 | 0.88 | CNR2 (0.79) | CNR2CNR1 | |
| SCHEMBL925525 | 0.88 | CNR2 (0.79) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773783-B1 | METHOD FOR PREPARING N-PIPERIDINO-1,5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | SANOFI AVENTIS (FR) | 2010-05-05 | — | — | EP | claimed |
| US-7462632-B2 | Method for the preparation of N-piperidino-1, 5-diphenylpyrazole-3-carboxamide derivatives | SANOFI-AVENTIS (FR) | 2008-12-09 | — | — | US | claimed |
| US-20080119653-A1 | METHOD FOR THE PREPARATION OF N-PIPERIDINO-1, 5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | SANOFI-AVENTIS (FR) | 2008-05-22 | — | — | US | claimed |
| EP-1773783-A1 | METHOD FOR PREPARING N-PIPERIDINO-1,5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | Sanofi-Aventis (FR) | 2007-04-18 | — | — | EP | claimed |
| WO-2006021652-A1 | METHOD FOR PREPARING N-PIPERIDINO-1,5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | SANOFI-AVENTIS (FR) | 2006-03-02 | — | — | WO | claimed |
| WO-2025040089-A1 | NOVEL HETEROCYCLIC COMPOUND FOR SELECTIVELY REGULATING CANNABINOID CB1 FUNCTION | 德睿智药(苏州)新药研发有限公司 | 2025-02-27 | — | — | WO | disclosed |
| EP-1773783-B1 | METHOD FOR PREPARING N-PIPERIDINO-1,5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | SANOFI AVENTIS (FR) | 2010-05-05 | — | — | EP | disclosed |
| US-20100076197-A1 | PROCESS FOR RIMONABANT | HETERO DRUGS LIMITED (IN) | 2010-03-25 | — | — | US | disclosed |
| US-7632852-B2 | (1,5-diphenyl-1H-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics | SANOFI-AVENTIS (FR) | 2009-12-15 | — | — | US | disclosed |
| WO-2009109222-A1 | PROCESS FOR THE PREPARATION OF RIMONABANT | MAPRIMED, S. A. (AR) | 2009-09-11 | — | — | WO | disclosed |
| EP-2061783-A2 | IMPROVED PROCESS FOR RIMONABANT | Hetero Drugs Limited (IN) | 2009-05-27 | — | — | EP | disclosed |
| US-7462632-B2 | Method for the preparation of N-piperidino-1, 5-diphenylpyrazole-3-carboxamide derivatives | SANOFI-AVENTIS (FR) | 2008-12-09 | — | — | US | disclosed |
| US-20080119653-A1 | METHOD FOR THE PREPARATION OF N-PIPERIDINO-1, 5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | SANOFI-AVENTIS (FR) | 2008-05-22 | — | — | US | disclosed |
| US-20080119653-A1 | METHOD FOR THE PREPARATION OF N-PIPERIDINO-1, 5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | SANOFI-AVENTIS (FR) | 2008-05-22 | — | — | US | disclosed |
| WO-2008032330-A2 | IMPROVED PROCESS FOR RIMONABANT | HETERO DRUGS LIMITED (IN) | 2008-03-20 | — | — | WO | disclosed |
| US-20080039510-A1 | (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS | SANOFI-AVENTIS (FR) | 2008-02-14 | — | — | US | disclosed |
| EP-1853595-A1 | (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS | Sanofi-Aventis (FR) | 2007-11-14 | — | — | EP | disclosed |
| EP-1773783-A1 | METHOD FOR PREPARING N-PIPERIDINO-1,5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | Sanofi-Aventis (FR) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006087480-A1 | (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS | SANOFI-AVENTIS (FR) | 2006-08-24 | — | — | WO | disclosed |
| WO-2006021652-A1 | METHOD FOR PREPARING N-PIPERIDINO-1,5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | SANOFI-AVENTIS (FR) | 2006-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039510-A1 | (1,5-DIPHENYL-1H-PYRAZOL-3-YL)OXADIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS | DHFR, DPYD, THPO | CNR2 933/4885CNR1 767/4885 |
| US-20100076197-A1 | PROCESS FOR RIMONABANT | CNR1, CNR2, AADAT | CNR2 2/4885CNR1 1/4885 |
| US-20080119653-A1 | METHOD FOR THE PREPARATION OF N-PIPERIDINO-1, 5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES | HRH2, NUDT1, P2RY4 | CNR2 220/4885CNR1 349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.